NRIX Nurix Therapeutics, Inc.
Healthcare$17.38-0.69%ClosedMarket Cap: $1.51B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$32.20
Target (Median)
$32.00
Target Range
$28.00 - $36.00
Upside from current price: 85.3%
Rating Distribution
5 Strong Buy12 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-18 | BTIG | maintain | Buy | Buy |
| 2026-04-27 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-23 | Needham | maintain | Buy | Buy |
| 2026-04-09 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-03-24 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-29 | Needham | maintain | Buy | Buy |
| 2026-01-29 | Stifel | maintain | Buy | Buy |
| 2026-01-29 | RBC Capital | maintain | Outperform | Outperform |
| 2026-01-29 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-01-29 | Wells Fargo | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Tue Nov 30 | $-2.83 | $74.2M | 12 |
| Thu Nov 30 | $-2.25 | $130.0M | 11 |
| Fri Nov 30 | $-1.66 | $262.1M | 4 |
| Sat Nov 30 | $-0.33 | $490.9M | 4 |